1. Home
  2. DGX vs SYF Comparison

DGX vs SYF Comparison

Compare DGX & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGX
  • SYF
  • Stock Information
  • Founded
  • DGX 1967
  • SYF 1932
  • Country
  • DGX United States
  • SYF United States
  • Employees
  • DGX N/A
  • SYF N/A
  • Industry
  • DGX Medical Specialities
  • SYF Finance: Consumer Services
  • Sector
  • DGX Health Care
  • SYF Finance
  • Exchange
  • DGX Nasdaq
  • SYF Nasdaq
  • Market Cap
  • DGX 19.2B
  • SYF 20.3B
  • IPO Year
  • DGX 1996
  • SYF N/A
  • Fundamental
  • Price
  • DGX $175.90
  • SYF $55.45
  • Analyst Decision
  • DGX Buy
  • SYF Buy
  • Analyst Count
  • DGX 14
  • SYF 21
  • Target Price
  • DGX $185.07
  • SYF $62.00
  • AVG Volume (30 Days)
  • DGX 1.4M
  • SYF 4.4M
  • Earning Date
  • DGX 04-22-2025
  • SYF 04-22-2025
  • Dividend Yield
  • DGX 1.82%
  • SYF 2.16%
  • EPS Growth
  • DGX 6.41
  • SYF 4.77
  • EPS
  • DGX 7.91
  • SYF 7.27
  • Revenue
  • DGX $10,158,000,000.00
  • SYF $8,705,000,000.00
  • Revenue This Year
  • DGX $10.28
  • SYF $94.67
  • Revenue Next Year
  • DGX $4.05
  • SYF $8.22
  • P/E Ratio
  • DGX $22.24
  • SYF $7.63
  • Revenue Growth
  • DGX 9.38
  • SYF 0.44
  • 52 Week Low
  • DGX $135.47
  • SYF $40.55
  • 52 Week High
  • DGX $179.32
  • SYF $70.93
  • Technical
  • Relative Strength Index (RSI)
  • DGX 57.57
  • SYF 61.71
  • Support Level
  • DGX $175.25
  • SYF $52.99
  • Resistance Level
  • DGX $179.32
  • SYF $54.81
  • Average True Range (ATR)
  • DGX 3.80
  • SYF 1.72
  • MACD
  • DGX 0.30
  • SYF 0.78
  • Stochastic Oscillator
  • DGX 82.28
  • SYF 94.33

About DGX Quest Diagnostics Incorporated

Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: